Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

INTRODUCTION: Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic adenocarcinoma (PC), but the use of multimodality therapy was uncommon in these series. We evaluated long-term survival and patterns of recurrence in patients treated for PC with contemporar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Katz, Matthew H. G., Wang, Huamin, Fleming, Jason B., Sun, Charlotte C., Hwang, Rosa F., Wolff, Robert A., Varadhachary, Gauri, Abbruzzese, James L., Crane, Christopher H., Krishnan, Sunil, Vauthey, Jean-Nicolas, Abdalla, Eddie K., Lee, Jeffrey E., Pisters, Peter W. T., Evans, Douglas B.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3066077/
https://ncbi.nlm.nih.gov/pubmed/19194760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-008-0295-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items